Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02519452
Brief Title: A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

First Submitted : August 6, 2015
First Submitted that Met QC Criteria : August 6, 2015
First Posted : August 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 11, 2022
Last Update Posted : August 12, 2022